What does Invivo Therapeutics Holdings Corp. do?

Jun 22 2025 06:46 PM IST
share
Share Via
Invivo Therapeutics Holdings Corp. is a biotechnology company focused on developing biopolymer-scaffolding devices for spinal cord injury treatment. As of September 2023, it has a market cap of $1.15 million and reported a net profit loss of $3 million.
Overview:
Invivo Therapeutics Holdings Corp. is a research and clinical-stage biotechnology company focused on developing and commercializing biopolymer-scaffolding devices for the treatment of spinal cord injuries (SCI) within the micro-cap market.

Financial Snapshot:
Most recent Net Profit: -3 Million (Quarterly Results - Sep 2023)
Market cap: USD 1.15 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -0.96
Return on Equity: -104.59%
Price to Book: 0.13

Contact Details:
Address: 1 Kendall Sq Fl 4, CAMBRIDGE MA: 02139-1562
Tel: 1 617 8635524
Website: http://www.invivotherapeutics.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News